Minneapolis, MN, United States of America

Cprx Inc.


USPTO Granted Patents = 16

Trademarks = 1

Forward Citations = 2,282

Loading Chart...
Loading Chart...

11 inventors (with patents filed for the assignee):

goldMedal Keith G Lurie (16 out of 111 patents)

silverMedal Todd M Zielinski (7 out of 41 patents)

bronzeMedal Barbara S Gold (4 out of 7 patents)

4 Michael F Sweeney (4 out of 5 patents)

5 Robert Patterson (3 out of 10 patents)

6 Wolfgang Voelckel (3 out of 5 patents)

7 David G Benditt (3 out of 11 patents)

8 Scott McKnite (2 out of 3 patents)

9 Karl Lindner (2 out of 2 patents)

10 Nemer Samniah (2 out of 2 patents)

11 Wolfgang Voeckel (1 out of 1 patent)


16 patents:

Cprx Inc. is a biopharmaceutical company focused on developing and commercializing innovative drugs for the treatment of rare neurological diseases. The company's lead product, Firdapse, is approved for the treatment of Lambert-Eaton Myasthenic Syndrome (LEMS). Cprx Inc. is dedicated to improving the lives of patients with rare diseases through its cutting-edge research and development efforts.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Sep 15 2026

16 Patents

#114 in Minneapolis, MN

#592 in Minnesota

#19,875 in US

#37,723 in the World

Minneapolis, MN (US)
Minneapolis, MN, United States of America
Forward Citations = 2,282

11 inventors:

Please report any incorrect information to [email protected]
Loading…